The phenotype of Sotos syndrome in adulthood: A review of 44 individuals.


Journal

American journal of medical genetics. Part C, Seminars in medical genetics
ISSN: 1552-4876
Titre abrégé: Am J Med Genet C Semin Med Genet
Pays: United States
ID NLM: 101235745

Informations de publication

Date de publication:
12 2019
Historique:
received: 18 04 2019
revised: 09 07 2019
accepted: 10 07 2019
pubmed: 4 9 2019
medline: 6 5 2020
entrez: 4 9 2019
Statut: ppublish

Résumé

Sotos syndrome is an overgrowth-intellectual disability (OGID) syndrome caused by NSD1 pathogenic variants and characterized by a distinctive facial appearance, an intellectual disability, tall stature and/or macrocephaly. Other associated clinical features include scoliosis, seizures, renal anomalies, and cardiac anomalies. However, many of the published Sotos syndrome clinical descriptions are based on studies of children; the phenotype in adults with Sotos syndrome is not yet well described. Given that it is now 17 years since disruption of NSD1 was shown to cause Sotos syndrome, many of the children first reported are now adults. It is therefore timely to investigate the phenotype of 44 adults with Sotos syndrome and NSD1 pathogenic variants. We have shown that adults with Sotos syndrome display a wide spectrum of intellectual ability with functioning ranging from fully independent to fully dependent. Reproductive rates are low. In our cohort, median height in adult women is +1.9 SD and men +0.5 SD. There is a distinctive facial appearance in adults with a tall, square, prominent chin. Reassuringly, adults with Sotos syndrome are generally healthy with few new medical issues; however, lymphedema, poor dentition, hearing loss, contractures and tremor have developed in a small number of individuals.

Identifiants

pubmed: 31479583
doi: 10.1002/ajmg.c.31738
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

502-508

Subventions

Organisme : Wellcome Trust
ID : 100210
Pays : United Kingdom
Organisme : National Institute for Health Research
Pays : International
Organisme : Child Growth Foundation
ID : GR01/13
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Allanson, J. E., & Cole, T. R. P. (1996). Sotos syndrome: Evolution of facial phenotype subjective and objective assessment. American Journal of Medical Genetics, 65, 13-20.
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., … Zhang, Y. (2002). Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science, 298, 1039-1043. https://doi.org/10.1126/science.1076997
Cole, T. R., & Hughes, H. E. (1994). Sotos syndrome: A study of the diagnostic criteria and natural history. Journal of Medical Genetics, 31, 20-32. https://doi.org/10.1136/JMG.31.1.20
Fickie, M. R., Lapunzina, P., Gentile, J. K., Tolkoff-Rubin, N., Kroshinsky, D., Galan, E., … Lin, A. E. (2011). Adults with Sotos syndrome: Review of 21 adults with molecularly confirmed NSD1 alterations, including a detailed case report of the oldest person. American Journal of Medical Genetics, Part A, 155, 2105-2111. https://doi.org/10.1002/ajmg.a.34156
Harries, M. L., Walker, J. M., Williams, D. M., Hawkins, S., & Hughes, I. A. (1997). Changes in the male voice at puberty. Archives of Disease in Childhood, 77, 445-447. https://doi.org/10.1136/adc.77.5.445
Hood, R. L., Mcgillivray, G., Hunter, M. F., Roberston, S. P., Bulman, D. E., Boycott, K. M., … Dyment, D. (2016). Severe connective tissue laxity including aortic dilatation in Sotos syndrome. American Journal of Medical Genetics, Part A, 170, 531-535. https://doi.org/10.1002/ajmg.a.37402
Huang, N., vom Baur, E., Garnier, J. M., Lerouge, T., Vonesch, J. L., Lutz, Y., … Losson, R. (1998). Two distinct nuclear receptor interation domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators. The EMBO Journal, 17, 3398-3412. https://doi.org/10.1093/emboj/17.12.3398
Kurotaki, N., Imaizumi, K., Harada, N., Masuno, M., Kondoh, T., Nagai, T., … Matsumoto, N. (2002). Haploinsufficiency of NSD1 causes Sotos syndrome. Nature Genetics, 30, 365-366. https://doi.org/10.1038/ng863
Lapunzina, P. (2005). Risk of tumorigenesis in overgrowth syndromes: A comprehensive review. American Journal of Medical Genetics, Part C, 137C, 53-71. https://doi.org/10.1002/ajmg.c.30064
Marshall, W. a., & Tanner, J. M. (1970). Variations in the pattern of pubertal changes in boys. Archives of Disease in Childhood, 45, 13-23. https://doi.org/10.1136/adc.45.239.13
McClelland, J., Burgess, B., Crock, P., & Goel, H. (2016). Sotos syndrome: An unusual presentation with intrauterine growth restriction, generalised lymphedema, and intention tremor. American Journal of Medical Genetics, Part A, 170A, 1064-1069. https://doi.org/10.1002/ajmg.a.37535
Rayasam, G. V., Wendling, O., Angrand, P. O., Mark, M., Niederreither, K., Song, L., … Losson, R. (2003). NSD1 is essential for early post-implantation development and has a catalytically active SET domain. EMBO Journal, 22, 3153-3163. https://doi.org/10.1093/emboj/cdg288
Robertson, S., & Bankier, A. (1999). Sotos syndrome and cutis laxa. Journal of Medical Genetics, 36, 51-56.
Schaefer, G. B., Bodensteiner, J. B., Buehler, B. A., Lin, A., & Cole, T. R. P. (1997). The neuroimaging findings in Sotos syndrome. American Journal of Medical Genetics, 68, 462-465.
Sotos, J. F., Dodge, P. R., Muirhead, D., Crawford, J. D., & Talbot, N. B. (1964). Cerebral gigantism in childhood--A syndrome of excessively rapid growth with acromegalic features and a nonprogressive neurologic disorder. The New England Journal of Medicine, 271, 109-116. https://doi.org/10.1056/NEJM196407162710301
Tatton-Brown, K., Cole, T. R. P., & Rahman, N. (2004). Sotos syndrome. In M. P. Adam, H. H. Ardinger, R. A. Pagon et al., (Eds.). GeneReviews® [Internet]. Seattle (WA): University of Washington; 1993-2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1479
Tatton-Brown, K., Douglas, J., Coleman, K., Baujat, G., Cole, T. R. P., Das, S., … Childhood Overgrowth Collaboration, C. O. (2005). Genotype-phenotype associations in Sotos syndrome: An analysis of 266 individuals with NSD1 aberrations. American Journal of Human Genetics, 77, 193-204. https://doi.org/10.1086/432082
Whincup, P. H., Gilg, J., Odoki, K., Taylor, S., & Cook, D. (2001). Age of menarche in contemporary British teenagers: Survey of girls born between 1982 and 1986. British Medical Journal, 322, 1095-1096. https://doi.org/10.1136/bmj.322.7294.1095

Auteurs

Alison Foster (A)

University of Birmingham, Institution of Cancer and Genomic Sciences, Birmingham, UK.
West Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women and Children's NHS Foundation Trust, Birmingham, UK.

Anna Zachariou (A)

Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.

Chey Loveday (C)

Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.

Tazeen Ashraf (T)

Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Edward Blair (E)

Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Jill Clayton-Smith (J)

Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.

Huw Dorkins (H)

Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK.

Alan Fryer (A)

Department of Clinical Genetics, Liverpool Women's NHS Foundation Trust, Liverpool, UK.

Blanca Gener (B)

Department of Genetics, Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.

David Goudie (D)

East of Scotland Regional Genetics Service, Ninewells Hospital and Medical School, Dundee, UK.

Alex Henderson (A)

Northern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Melita Irving (M)

Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Shelagh Joss (S)

West of Scotland Regional Genetics Service, Laboratory Medicine Building, Queen Elizabeth University Hospital, Glasgow, UK.

Vaughan Keeley (V)

University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.

Nayana Lahiri (N)

South West Thames Regional Genetics Service, St George's University Hospitals NHS Foundation Trust, London, UK.

Sally Ann Lynch (SA)

Department of Clinical Genetics, Temple Street Children's University Hospital, Dublin, Ireland.

Sahar Mansour (S)

South West Thames Regional Genetics Service, St George's University Hospitals NHS Foundation Trust, London, UK.
St George's University of London, London, UK.

Emma McCann (E)

Department of Clinical Genetics, Liverpool Women's NHS Foundation Trust, Liverpool, UK.

Jenny Morton (J)

West Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women and Children's NHS Foundation Trust, Birmingham, UK.

Nicole Motton (N)

West Midlands Regional Genetics Service, Birmingham Women's Hospital, Birmingham, UK.

Alexandra Murray (A)

All Wales Medical Genomics Service, University Hospital of Wales, Cardiff, UK.

Katie Riches (K)

University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.

Deborah Shears (D)

Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Zornitza Stark (Z)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Australia.

Elizabeth Thompson (E)

SA Clinical Genetics Service, Women's and Children's Hospital, Adelaide, South Australia, Australia.
Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia.

Julie Vogt (J)

West Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women and Children's NHS Foundation Trust, Birmingham, UK.

Michael Wright (M)

Northern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Trevor Cole (T)

West Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women and Children's NHS Foundation Trust, Birmingham, UK.

Katrina Tatton-Brown (K)

Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
South West Thames Regional Genetics Service, St George's University Hospitals NHS Foundation Trust, London, UK.
St George's University of London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH